Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announced results for the fourth quarter and year ended December 31, 2009.
* Cubist acquired Calixa Therapeutics Inc. in December
* Operating income grew 52% over 2008
* Total net revenues for 2009 increased 30% over 2008

Related posts

Biomet Announces Financial [...]

Continue reading " Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million "

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) provided an update to the preliminary revenue and adjusted earnings per share growth rate guidance provided to investors at the Company’s recent analyst R&D day meeting on December 3, 2009. The Company now believes that the 2010 overall revenue percentage growth rate will be in the mid-teens and re-affirms that [...]

Continue reading " OSI Pharmaceuticals Updates Preliminary Revenue & Re-affirms Adjusted Earnings Growth Rate Guidance for 2010 "

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, Numbers are in Thousands) announced best ever Company quarterly and annual fiscal year results, topping one hundred million in net revenue during the quarter for the first time.

Related posts

Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million [...]

Continue reading " Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal Year "

AmerisourceBergen Corporation (NYSE: ABC) will announce at its Investor Meeting in New York City that in the December 2009 quarter, it expects diluted earnings per share to be several cents above the current consensus of $0.43, due primarily to expected revenue growth of more than 10 percent in the December quarter and the contribution from [...]

Continue reading " AmerisourceBergen Expects Strong December 2009 Quarter Pushing Guidance for FY2010 to the Higher End of Its Range "

Angeion Corporation (NASDAQ: ANGN) reported results for its fiscal fourth quarter ended October 31, 2009.
Highlights
* Fourth quarter revenue of $6.6 million was sequentially up from third quarter
* Cash increased to $11.2 million, up $2.2 million from prior year-end
* Gross margin for the year [...]

Continue reading " Angeion Corporation Reports Fiscal 2009 Fourth-Quarter & Year-End Results "

Del Global Technologies Corp. (OTCBB: DGTC) (“Del Global” or “the Company”) announced financial results for its fiscal 2010 first quarter.
Highlights
* FY 2010 first quarter sales from continuing operations were $11.6 million reflecting soft customer demand
* FY 2010 first quarter loss from continuing operations was $0.4 million, or [...]

Continue reading " Del Global Technologies Reports Fiscal 2010 First Quarter Financial Results "

Synovis Life Technologies, Inc. (NASDAQ: SYNO), reported strong revenue performance for the fourth fiscal quarter and full fiscal year ended Oct. 31, 2009.
For the 2009 fiscal fourth quarter, net revenue rose to $15.0 million, an 18 percent increase over $12.7 million in the year-ago period. Net income on a GAAP basis for the fiscal 2009 [...]

Continue reading " Synovis Life Technologies Reports 18 Percent Revenue Growth for Fiscal 2009 Fourth Quarter "

BioTime, Inc. (NYSE Amex:BTIM) reported financial results for the quarter ended September 30, 2009 and an update.
For the three months ended September 30, 2009, BioTime’s total quarterly revenue (including royalty income, revenue recognition of deferred license fees, and grant income) increased 5% to $446,993 from $426,931 for the same period last year.

Related posts

AVANIR Pharmaceuticals Announces [...]

Continue reading " BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments "

Dynacq Healthcare, Inc. (DYII) reported a loss from continuing operations for the year ended August 31, 2009 of $0.03 per share compared to income from continuing operations of $0.32 per share in the previous year. The share amounts are calculated on a fully diluted basis.

Related posts

AVANIR Pharmaceuticals Announces Fiscal 2010 First Quarter Financial Results (0)
Medical [...]

Continue reading " Dynacq Healthcare, Inc. Announces Financial Results for the Year Ended August 31, 2009 "

SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, reported operational and financial results for its fourth quarter and fiscal year ended September 30, 2009.
SeraCare delivered revenue of $12.5 million for the quarter ended September 30, [...]

Continue reading " SeraCare Reports Fourth Quarter and Fiscal Year 2009 Results "